Category: Health

Health

Ampronix, LLC the Leader in Medical Imaging Technology Announces New CEO A. Burton Tripathi PhD

Ampronix, LLC the Leader in Medical Imaging Technology Announces New CEO A. Burton Tripathi PhDFor over 40 years, Ampronix has led the way in medical imaging innovation and design. The name “Ampronix” has become synonymous with excellence, and Ampronix has evolved into a renowned master distributor of the medical industry’s top brands.

Ampronix, LLC the Leader in Medical Imaging Technology Announces New CEO A. Burton Tripathi PhD
Ampronix LLC CEO A. Burton Tripathi PhD
Ampronix LLC CEO A. Burton Tripathi PhD

IRVINE, Calif. – December 30, 2022 – (Newswire.com)

Founded in 1982 and located in Irvine, California, Ampronix, LLC is a renowned authorized master distributor of the medical industry’s top brands currently selling to 154+ countries as well as a world-class manufacturer of innovative technology. We are happy to announce A. Burton Tripathi, Ph.D., as CEO. Dr. Tripathi succeeds Aladdin Doroudi, who is retiring and has guided the company to its strong position in the market through his dedicated leadership over the last 22 years.

About A. Burton Tripathi PhD

Before Ampronix, LLC, Dr. Tripathi was Head of Visualization R&D at Alcon Inc. He guided the strategic planning, ideation, development, and launch of the next generation of visualization equipment -transforming the practice of surgery with a fully digital operating microscope. 

Before Alcon, Dr. Tripathi was the CEO of TrueVision Systems, Inc.

Dr. Tripathi negotiated and led a $145M sale and integration of TrueVision Systems to Alcon. In 2018 Dr. Tripathi guided the complex legal and financial transaction of spinning out the non-ophthalmology business of TrueVision into TrueDigital Surgery. This complex structure provided a win-win solution, preserving jobs and allowing both Alcon and TrueDigital to maximize shareholder value while continuing to deliver cutting-edge solutions. 

Before helming TrueVision Systems, Dr. Tripathi served as Chief Technology Officer and VP, Product Development, leading passionate teams of 50+ engineers and support staff in the mission to revolutionize microsurgery by bringing 3D digital imaging with Augmented Reality (AR) to the optical microscope. Dr. Tripathi’s team worked to change the face of neurosurgery, ophthalmology, and other surgical disciplines by improving surgical precision, enabling new digital applications, and inventing new technologies. 

Dr. Tripathi holds a Ph.D. from the California Institute of Technology in Mechanical Engineering and a B.S. in Mechanical and Aerospace Engineering from Cornell University. 

About Ampronix, LLC

Ampronix was recently awarded the “President’s E-Award,” the highest honor given to U.S. exporters and Exporter of the Year for Orange County, California. Ampronix is proud to represent customers worldwide through its dedication to meeting the growing needs of the medical community with its extensive product knowledge, outstanding customer service, and groovy team of sales professionals. Ampronix has focused on putting clients’ satisfaction first, as professionalism is their cornerstone. Ampronix has been an established member of the Irvine community since its inception in 1982. Ampronix is a beacon in the community and continually strives to increase its global presence through industry-leading exporting efforts. With reliability, safety, and quality at the core of its philosophy, Ampronix is dedicated to helping others save lives and create a healthier tomorrow for future generations.

Contact Information:

Michael Thomas

Director of Marketing
[email protected]

949-273-8000

Press Release Service
by
Newswire.com

Original Source:

Ampronix, LLC the Leader in Medical Imaging Technology Announces New CEO A. Burton Tripathi PhD

Continue Reading

Health

Physicians for Informed Consent (PIC) Updates Its ‘Aluminum – Vaccine Risk Statement’: Document Includes Data on Association Between Aluminum in Vaccines and Childhood Asthma

Physicians for Informed Consent (PIC) Updates Its ‘Aluminum – Vaccine Risk Statement’: Document Includes Data on Association Between Aluminum in Vaccines and Childhood AsthmaAccording to PIC, adverse effects of aluminum may not be restricted to neurological conditions*

NEWPORT BEACH, Calif. – December 28, 2022 – (Newswire.com)

Physicians for Informed Consent (PIC) has released an update to its Aluminum  – Vaccine Risk Statement (VRS) titled “Aluminum in Vaccines: What Parents Need to Know.” The concise, two-page educational document — which serves to answer important questions about the risks of aluminum-containing vaccines — now includes important data about a study’s link between aluminum in vaccines and asthma. Asthma is a disease that affects the lungs. It causes repeated episodes of wheezing, breathlessness, chest tightness, and nighttime or early morning coughing.

Developed from data compiled by the Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), and the Agency for Toxic Substances and Disease Registry (ATSDR), the PIC document provides reader-friendly Q&As on topics such as:

  • Why is aluminum in vaccines?
  • Which vaccines contain aluminum?
  • How much aluminum is in vaccines?
  • Is exposure to aluminum from vaccines safe?

The document explains that both the FDA and ATSDR have raised concerns about the negative effects of aluminum exposure in humans. Scientific studies have shown that small amounts of aluminum can interfere with cellular and metabolic processes in the nervous system. Some of the most damaging effects of aluminum range from motor skill impairment to encephalopathy (altered mental state, personality changes, difficulty thinking, loss of memory, seizures, coma, and more).

Studies have also shown that adverse effects of aluminum may not be restricted to neurological conditions.* A study referenced in the PIC document and published in Academic Pediatrics found that asthma occurred in 1 in 183 vaccinated children for every 1 mg (1,000 mcg) increase in aluminum exposure. In the United States, up to 22 doses of aluminum-containing vaccines are administered to children, with 11 doses administered from birth to 6 months of age. 

“Overexposure to aluminum may lead to significant harm,” said Dr. Shira Miller, founder and president of Physicians for Informed Consent. “In California, where PIC is headquartered, since Senate Bill 277 (SB 277) was enacted in 2015, numerous doses of aluminum-containing vaccines are mandated for public and private K-12 school attendance — with no exceptions for religious or personal belief exemptions. PIC asserts that vaccine mandates are unscientific and unethical and a threat to public health. SB 277, and any other law that coerces vaccination, needs to be repealed.”

To read or download the educational document “Aluminum in Vaccines: What Parents Need to Know,” please visit physiciansforinformedconsent.org/aluminum.

* In 2008, the Agency for Toxic Substances and Disease Registry (ATSDR), a division of HHS, used studies of the neurotoxic effects of aluminum to determine that no more than 1 milligram (mg) (1,000 micrograms [mcg]) of aluminum per kilogram (kg) of body weight should be taken orally per day to avoid aluminum’s negative effects.

Physicians for Informed Consent is a 501(c)(3) nonprofit educational organization focused on science and statistics. PIC delivers data on infectious diseases and vaccines, and unites doctors, scientists, healthcare professionals, attorneys, and families who support voluntary vaccination. In addition, the PIC Coalition for Informed Consent consists of over 300 U.S. and international organizations. Click here to make a donation.

Contact Information:

Greg Glaser

General Counsel
[email protected]

925-642-6651

Press Release Service
by
Newswire.com

Original Source:

Physicians for Informed Consent (PIC) Updates Its ‘Aluminum – Vaccine Risk Statement’: Document Includes Data on Association Between Aluminum in Vaccines and Childhood Asthma

Continue Reading